The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision-making. However, emerging ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Tocilizumab, an interleukin-6 receptor ...

Electrocardiography is performed in the emergency department to test for myocardial infarction. Image courtesy of Harrington et al. A 56-year-old woman presents to a rural emergency department with ...

The effects of regionalized STEMI treatment protocols do not seem to have positively or negatively affected patients diagnosed with NSTEMI, according to new California registry data. The widespread ...

Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...

DENVER — Patients with inflammatory bowel disease and non-ST elevation myocardial infarction had higher mortality, hospital stays and hospital charges than patients with IBD alone, noted a presenter ...

Patients with STEMI undergoing PCI who received an intravenous dose of tocilizumab, an inhibitor of the inflammatory cytokine interkleukin-6 (IL-6), prior to their procedure appeared to have less ...

A Japanese registry study reveals how DanGer shock criteria predict survival in heart attack patients treated with Impella.

In a recent study published in the Journal of the American Heart Association, researchers assessed midterm and management outcomes of acute myocardial infarction (AMI) among patients with rheumatic ...